Evaluation of Success Rate of Partial Pulpotomy Versus Complete Pulpotomy in Primary Molars Using NeoPUTTY MTA

August 13, 2024 updated by: Yara Ayman, Cairo University

Clinical and Radiographic Evaluation of Partial Pulpotomy Versus Complete Pulpotomy in Vital Pulp Therapy in Primary Molars Using NeoPUTTY™ (MTA): Randomized Clinical Trial

Evaluating the clinical and radiographic success of partial pulpotomy compared to complete pulpotomy in vital primary second molars with reversible pulpitis using NeoPUTTY™ (MTA).

Study Overview

Status

Not yet recruiting

Detailed Description

Children with symptoms of reversible pulpitis in their second primary molar will be chosen to be enrolled in the study, and then randomly allocated into two groups. One group will undergo partial pulpotomy and the other group complete pulpotomy and followed up for 12 months. The blinding of the operator is not possible due to the nature of the technique used. Trial participants, outcome assessors and statistician will be blinded.

  1. Informed consent from participating children's parents.
  2. Baseline records photographs, percussion test, periapical radiograph and personal data collection.
  3. Diagnostic chart with personal, medical and dental history will be filled.
  4. Allocation (concealed by withdrawing a sealed opaque envelope containing Four-folded numbered papers containing the type of vital pulp therapy technique that will be used then writing the patient's name and I.D. on it and will be opened after removing the carious lesion).
  5. Clinical examination will be performed to assess the clinical inclusion criteria. (Pulpal and periapical diagnoses are established after clinical examination).
  6. Preoperative and Postoperative photographs will be taken.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients:

    • Aged 4-7 years, in good general health and medically within normal.

Teeth:

  • Restorable mandibular second primary molars.
  • History of reversible pulpitis.

Preoperative radiograph:

  • Absence of periapical or inter-radicular radiolucency.
  • Absence of widening of periodontal ligaments (PDL) space.
  • Absence of internal or external root resorption.

Exclusion Criteria:

  • Patients:

    • With systemic disorders.
    • Physical or mental disabilities.
    • Unable to attend follow-up visits.
    • Refusal of Participation.
    • Refusal to sign the informed consent.

Teeth:

  • Previously accessed teeth.
  • Mobile mandibular second primary molar.
  • Swelling in the vestibule or on palpation.
  • Pain on percussion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Complete pulpotomy
After removing caries with a large round bur, the access cavity will be opened. Excavation of inflamed coronal pulp tissues will be done using a sharp excavator. A sterile cotton pellet with saline will be placed with light pressure for 2-3 minutes to achieve hemostasis.
Experimental: Partial Pulpotomy
After removing caries high-speed handpiece with water coolant using a round diamond bur. Once there is an exposure, the bur is changed with another sterile one with which the superficially inflamed pulp tissue will be gently removed to a depth of 1-3 mm beneath the pinpoint pulp exposure that occurred at the end of caries removal. A sterile cotton pellet with saline will be placed with light pressure for 2-3 minutes to achieve hemostasis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative pain
Time Frame: one week postoperative
Postoperative pain assessment through Visual Analog Scale (the lower the value the better).
one week postoperative
Swelling/ Fistula
Time Frame: 3, 6, 9, 12 months
Assessment of swelling and fistula through visual examination.
3, 6, 9, 12 months
Mobility
Time Frame: 3, 6, 9, 12 months
Assesment of pathological mobility using mobility test.
3, 6, 9, 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Radiographic success
Time Frame: 0, 6, 12 months
Radiographic evaluation (Radiolucency at furcation or periapical, internal or external root resorption) through visual interpretation of digital radiograph at 0, 6 and 12 months postoperatively.
0, 6, 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Hany M. Saber, PHD, Faculty of Dental Medicine, Cairo University
  • Study Director: Hanaa M. Abd El Moniem, PHD, Faculty of Dental Medicine, Cairo University
  • Principal Investigator: Yara A. Badr, Masters, Faculty of Dental Medicine, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 22, 2024

Primary Completion (Estimated)

December 22, 2024

Study Completion (Estimated)

December 22, 2025

Study Registration Dates

First Submitted

July 22, 2024

First Submitted That Met QC Criteria

July 25, 2024

First Posted (Actual)

July 29, 2024

Study Record Updates

Last Update Posted (Actual)

August 14, 2024

Last Update Submitted That Met QC Criteria

August 13, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 28052024

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulp Disease, Dental

Clinical Trials on Partial Pulpotomy

Subscribe